AcelRx Pharmaceuticals In...

NASDAQ: ACRX · Real-Time Price · USD
0.86
0.06 (7.50%)
At close: Jan 09, 2024, 10:00 PM

AcelRx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13M -18.4M 47.76M -35.1M
Depreciation & Amortization
-121K 311K 1.65M 1.97M
Stock-Based Compensation
989K 1.73M 2.89M 4.61M
Other Working Capital
n/a -29K -1.69M -88K
Other Non-Cash Items
n/a -1.79M -79.23M -2.5M
Deferred Income Tax
n/a 703K n/a 810K
Change in Working Capital
n/a -1.54M -1.39M 203K
Operating Cash Flow
-12.68M -17.49M -28.33M -30M
Capital Expenditures
n/a -100K -364K -1.83M
Cash Acquisitions
n/a n/a -1.69M n/a
Purchase of Investments
-4.98M -3.65M -7.86M -70.46M
Sales Maturities Of Investments
8.76M 500K 46.36M 46.98M
Other Investing Acitivies
n/a 2.72M -1.69M -821K
Investing Cash Flow
3.78M -528K 36.45M -26.12M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -315K -249K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
12.02M 3.47M -507K 41.51M
Financial Cash Flow
12.04M 3.47M -507K 41.51M
Net Cash Flow
3.14M -14.55M 7.61M -14.61M
Free Cash Flow
-12.68M -17.59M -28.7M -31.83M